Search results for "modifier"

showing 10 items of 41 documents

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

2014

Introduction More than 70 common alleles are known to be involved in breast cancer (BC) susceptibility, and several exhibit significant heterogeneity in their associations with different BC subtypes. Although there are differences in the association patterns between BRCA1 and BRCA2 mutation carriers and the general population for several loci, no study has comprehensively evaluated the associations of all known BC susceptibility alleles with risk of BC subtypes in BRCA1 and BRCA2 carriers. Methods We used data from 15,252 BRCA1 and 8,211 BRCA2 carriers to analyze the associations between approximately 200,000 genetic variants on the iCOGS array and risk of BC subtypes defined by estrogen re…

Cancer ResearchReceptor ErbB-2Genes BRCA2BRCALOCIGenes BRCA1MODIFIERSVARIANTSErbB-2610 Medical sciences MedicineDuctalReceptorsMedicine and Health SciencesINVESTIGATORSBreastskin and connective tissue diseasesProgesteroneMedicine(all)Carcinoma Ductal BreastMiddle AgedAdult; Aged; Alleles; Breast Neoplasms; Carcinoma; Carcinoma Ductal Breast; Carcinoma Lobular; Female; Genetic Predisposition to Disease; Heterozygote; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Receptor ErbB-2; Receptors Estrogen; Receptors Progesterone; Genes BRCA1; Genes BRCA2; Cancer Research; OncologyOncologyReceptors EstrogenTUMOR SUBTYPESFemaleReceptors ProgesteroneReceptorResearch ArticleAdultHeterozygote610Breast NeoplasmsMEDULLARY CARCINOMAOVARIAN-CANCERLobularHumansGenetic Predisposition to DiseaseGENOME-WIDE ASSOCIATIONAllelesAgedNeoplasm StagingAdult; Aged; Alleles; Breast Neoplasms; Carcinoma; Carcinoma Ductal Breast; Carcinoma Lobular; Female; Genetic Predisposition to Disease; Heterozygote; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Receptor ErbB-2; Receptors Estrogen; Receptors Progesterone; Genes BRCA1; Genes BRCA2CONSORTIUMCarcinomaBRCA1EstrogenBRCA2Carcinoma LobularESTROGEN-RECEPTORGenesNeoplasm GradingBreast Cancer Research
researchProduct

Childhood adversity and psychosis: a systematic review of bio-psycho-social mediators and moderators.

2020

AbstractThe association between childhood adversity (CA) and psychosis has been extensively investigated in recent years. An increasing body of research has also focused on the mediating or moderating role of biological and psychological mechanisms, as well as other risk factors that might account for the link between CA and psychosis. We conducted a systematic search of the PsychINFO, Embase, Ovid, and Web of Science databases for original articles investigating the role of genetic vulnerabilities, environmental factors, psychological and psychopathological mechanisms in the association between CA and psychosis up to August 2019. We included studies with individuals at different stages of …

Child abuseBiopsychosocial modelMediation (statistics)Psychosisgene-environment correlationchild abuseEffect Modifier Epidemiologic03 medical and health sciences0302 clinical medicineAdverse Childhood ExperiencesmedicineHumanspsychotic experiencesSettore MED/25 - PsichiatriaApplied Psychologymechanismschildhood traumaGene-environment correlationmedicine.diseaseModeration030227 psychiatryPsychiatry and Mental healthMoodAdult Survivors of Child Adverse EventsPsychotic DisordersGene-Environment InteractionmaltreatmentPsychology030217 neurology & neurosurgeryClinical psychologyPsychopathologyPsychological medicine
researchProduct

Thymosin α1 and α-Inteferon with Cisplatin and Etoposide in Advanced Non-Small-Cell Lung Cancer: A Phase II Study

1993

In recent years, biological response modifiers (BRMs) have emerged as an important new class of agents for treating cancer. Agents such as interferon (IFN) and interleukin 2 (IL-2) have been reported to induce significant tumor regression in various types of cancer usually resistant to chemotherapy (1,12), but their use in non-small-cell lung cancer (NSCLC) has received little attention.

CisplatinChemotherapybusiness.industrymedicine.medical_treatmentCancerLewis lung carcinomamedicine.diseaseInterferonmedicineCancer researchBiological response modifiersbusinessLung cancerEtoposidemedicine.drug
researchProduct

Effect of kind and content of organo-modified clay on properties of PET nanocomposites

2011

In this work we report the properties of nanocomposite based on PET with two different samples of organically modified montmorillonites. In particular, we studied the effect of the filler concentration on morphology, rheology, and mechanical performance, focusing our attention on the effect of the degradation phenomena of the clay modifiers. The results indicate that at low clay level the morphology achieved is mainly intercalated. On increasing the filler level, coalescence and/or bad defragmentation phenomena induce a coarser morphology, as confirmed by XRD, SEM, and TEM observations. When a more polar organic modifier is used to modify the clay, the particle adhesion and distribution is …

Coalescence (physics)NanocompositeMaterials scienceMorphology (linguistics)nanocompositePolymers and PlasticsIntrinsic viscosityorganic modifierModulusGeneral Chemistrycomplex mixturesSurfaces Coatings and FilmsCrystallinityPETRheologyMaterials ChemistryComposite materialElongationdegradationJournal of Applied Polymer Science
researchProduct

THORACIC SYRINGOMYELIA IN A PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS

2015

We report a patient with bulba r - onset, clinically defined, sporadic amyotrophic lateral sclerosis bearing an isolated syringomyelia of the lower thoracic portion of the spinal cord. This is a very unusual association between two rare and progressive disorders, both affecting the spinal motoneurons. Syringomyelia might have acted as a phenotypic modifier in this ALS patient.

Community and Home Caremedicine.medical_specialtybusiness.industrymedicine.diseasePhenotypic modifierSpinal cordSurgerymedicine.anatomical_structureALS syringomyelia case reportmedicineSettore MED/26 - NeurologiaAmyotrophic lateral sclerosisbusinessSyringomyelia
researchProduct

P228 Cytomegalovirus Infection: is it a cause of flare-up in inflammatory bowel diseases?

2020

Abstract Background The presence of CMV in blood is quite common in patients with severe flares of ulcerative colitis (UC) and Crohn’s disease (CD) and seems to predict an adverse outcome. The impact of antiviral treatment on CMV in this setting (indications and drug options) is an unresolved issue. Our aim was to reassess the CMV role in patients with IBD hospitalised for severe exacerbations, analysing the relationship between CMV positivity, clinical characteristics, antiviral therapy and disease outcomes. Methods We evaluated a homogeneous cohort of 97 consecutive patients with IBD hospitalised from 2012 to 2018. Data regarding age, gender, smoke, familial predisposition, type of IBD, e…

Crohn's diseasebusiness.industrymedicine.medical_treatmentGastroenterologyInflammatory Bowel DiseasesGeneral Medicinemedicine.diseaseInflammatory bowel diseaseUlcerative colitisCytomegalovirus infectionImmunologymedicineFlare upBiological response modifiersbusinessColectomyJournal of Crohn's and Colitis
researchProduct

Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase.

2009

The family of NFAT (nuclear factor of activated T-cells) transcription factors plays an important role in cytokine gene regulation. In peripheral T-cells NFATc1 and -c2 are predominantly expressed. Because of different promoter and poly(A) site usage as well as alternative splicing events, NFATc1 is synthesized in multiple isoforms. The highly inducible NFATc1/A contains a relatively short C terminus, whereas the longer, constitutively expressed isoform NFATc1/C spans an extra C-terminal peptide of 246 amino acids. Interestingly, this NFATc1/C-specific terminus can be highly sumoylated. Upon sumoylation, NFATc1/C, but not the unsumoylated NFATc1/A, translocates to promyelocytic leukemia nuc…

Gene isoformSUMO proteinBiologyBiochemistryHistone DeacetylasesCell LineMiceAnimalsHumansProtein IsoformsMolecular BiologyTranscription factorRegulation of gene expressionCell NucleusLymphokinesintegumentary systemNFATC Transcription FactorsActivator (genetics)Mechanisms of Signal TransductionNFATCell BiologyMolecular biologyChromatinHistoneGene Expression RegulationUbiquitin-Conjugating Enzymesbiology.proteinSmall Ubiquitin-Related Modifier ProteinsInterleukin-2Histone deacetylaseThe Journal of biological chemistry
researchProduct

Cytokines with Possible Clinical Utility

1987

Biological response modifiers (BRM) are agents aimed at reducing tumor growth, not primarily by exerting direct cytotoxic effects but by modulation of tumor gene expression (e.g., induction of differentiation) or by enhancing host defense mechanisms directed against cancer cells. BRM as primary therapy or as adjuncts to cytotoxic agents in the treatment of cancers have attracted increasing interest in view of stagnating clinical results in many areas [1], and there is increasing evidence of in vitro and in vivo efficacy of these agents. Furthermore, advances in molecular biology suggesting that oncogenes and their products play a crucial role in oncogenesis support approaches to modulation …

In vivoCancer cellCancer researchmedicineCytotoxic T cellBiological response modifiersBiologyCytotoxicityCarcinogenesismedicine.disease_causeHexamethylene bisacetamideIn vitro
researchProduct

Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA

2017

There is a renewed interest from the pharmaceutical field to develop oral formulations of compounds, such as peptides, oligonucleotides, and polar drugs. However, these often suffer from insufficient absorption across the intestinal mucosal barrier. One approach to circumvent this problem is the use of absorption modifying excipient(s) (AME). This study determined the absorption enhancing effect of four AMEs (sodium dodecyl sulfate, caprate, chitosan, N-acetylcysteine) on five model compounds in a rat jejunal perfusion model. The aim was to correlate the model compound absorption to the blood-to-lumen clearance of the mucosal marker for barrier integrity, 51Cr-EDTA. Sodium dodecyl sulfate a…

KetoprofenFysiologiPhysiologyabsorption modifiersPharmaceutical ScienceExcipient51cr edtaPharmacology and Toxicology02 engineering and technologyAbsorption (skin)030226 pharmacology & pharmacyChitosan03 medical and health scienceschemistry.chemical_compound0302 clinical medicineintestinal perfusionDrug DiscoverymedicineIntestinal transportSodium dodecyl sulfatebioequivalenceChromatographypermeation enhancersPermeationFarmakologi och toxikologi021001 nanoscience & nanotechnologypharmaceutical developmentchemistryMolecular Medicine0210 nano-technologymedicine.drugMolecular Pharmaceutics
researchProduct

Oppimiskontekstin vaikutus oppijanpragmatiikkaan : astemääritteet leksikaalisina nallekarhuina

2015

Artikkelissa käsitellään oppimisympäristön vaikutusta astemääritteiden käyttöön. Astemääritteet ovat jonkin ominaisuuden asteen suurta, kohtalaista tai vähäistä määrää ilmaisevia, pragmaattista merkitystä kantavia adverbeja (esim. melko, hyvin, tosi). Oppimisympäristön vaikutusta käsitellään artikkelissa korpusten avulla. Vaikka tällä hetkellä käytössä olevat oppijansuomen aineistot eivät ole täysin vertailukelpoisia keskenään esimerkiksi tekstien tehtävänantojen suhteen, voidaan niiden avulla tehdä alustavia havaintoja oppimiskontekstin vaikutuksesta ja edelleen hypoteeseja tulevia tutkimuksia varten. Oppimiskontekstilla tarkoitetaan tässä tutkimuksessa sitä ympäristöä, jossa kieltä opitaa…

Linguistics and Languageoppimiskontekstilearner languagelcsh:Finnic. Baltic-Finniclcsh:PH91-98.5avainsana-analyysita6121corporaoppijankieliLanguage and LinguisticskorpustutkimusN-gramsdegree modifierskorpuksetkeyword analysisastemääritteetn-grammitlearning contextLähivõrdlusi. Lähivertailuja
researchProduct